Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants
Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants have?
Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants has 10 citations in the OpenAlex counts ScholarIQ stores.
When was Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants published?
Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants has 2009 year in the ScholarIQ index.
What is the open-access status of Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants?
Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants has bronze oa status in the ScholarIQ index.
What is the DOI of Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants?
The DOI for Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants is on the source record.
What is the PMID of Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants?
The PMID for Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants is on the source record.
What is the OpenAlex record for Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants?
The OpenAlex for Antitumor activity of delimotecan against human metastatic melanoma: Pharmacokinetics and molecular determinants is on the source record.